Dr. De Cara’s recent research interests focus on identifying patients at risk for cardiovascular complications related to cancer therapeutics by using cardiac imaging techniques and examining clinical characteristics associated with increased cardiovascular risk.
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.
Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2025 Aug; 7(5):538-553.
PMID: 40668166
Echocardiographic Detection of Regional Wall Motion Abnormalities Using Artificial Intelligence Compared to Human Readers.
Echocardiographic Detection of Regional Wall Motion Abnormalities Using Artificial Intelligence Compared to Human Readers. J Am Soc Echocardiogr. 2024 Jul; 37(7):655-663.
PMID: 38556038
Diagnosis and Management of Aortic Diseases.
Diagnosis and Management of Aortic Diseases. JAMA. 2024 01 23; 331(4):352-353.
PMID: 38127327
Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021.
Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021. Am Heart J Plus. 2024 Feb; 38:100354.
PMID: 38510746
Diagnosis and Management of Aortic Diseases.
Diagnosis and Management of Aortic Diseases. JAMA. 2023 Dec 21.
PMID: 38127327
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative.
Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative. Circ Cardiovasc Qual Outcomes. 2023 10; 16(10):e009905.
PMID: 37702048
COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease.
COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease. Transl Oncol. 2023 Aug; 34:101709.
PMID: 37302348
Developing a Model for Cross-Institutional Educational Collaborations: The Chicago Cardio-Oncology Consortium (CCC) Experience.
Developing a Model for Cross-Institutional Educational Collaborations: The Chicago Cardio-Oncology Consortium (CCC) Experience. JACC CardioOncol. 2023 Apr; 5(2):262-266.
PMID: 37144102
Advances in Multimodality Imaging in Cardio-Oncology: JACC State-of-the-Art Review.
Advances in Multimodality Imaging in Cardio-Oncology: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 10 18; 80(16):1560-1578.
PMID: 36229093
Novel imaging paradigms for characterization of cardiovascular toxicities associated with cancer therapy.
Novel imaging paradigms for characterization of cardiovascular toxicities associated with cancer therapy. Am Heart J Plus. 2022 May; 17:100157.
PMID: 38559876